Literature DB >> 28880280

Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.

Amy E Baxter1,2, Julia Niessl1,2, Rémi Fromentin1, Jonathan Richard1, Filippos Porichis3, Marta Massanella1, Nathalie Brassard1, Nirmin Alsahafi1,4, Jean-Pierre Routy5, Andrés Finzi1,4, Nicolas Chomont1, Daniel E Kaufmann1,2.   

Abstract

Efforts to cure HIV are hampered by limited characterization of the cells supporting HIV replication in vivo and inadequate methods for quantifying the latent viral reservoir in individuals receiving antiretroviral therapy (ART). We describe a protocol for flow cytometric identification of viral reservoirs, based on concurrent detection of cellular HIV Gagpol mRNA by in situ RNA hybridization combined with antibody staining for the HIV Gag protein. By simultaneously detecting both HIV RNA and protein, the CD4 T cells harboring translation-competent virus can be identified. The HIVRNA/Gag method is 1,000-fold more sensitive than Gag protein staining alone, with a detection limit of 0.5-1 Gagpol mRNA+/Gag protein+ cells per million CD4 T cells. Uniquely, the HIVRNA/Gag assay also allows parallel phenotyping of viral reservoirs, including reactivated latent reservoirs in clinical samples. The assay takes 2 d, and requires antibody labeling for surface and intracellular markers, followed by mRNA labeling and multiple signal amplification steps.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28880280      PMCID: PMC5697908          DOI: 10.1038/nprot.2017.079

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  32 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

Review 2.  Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Authors:  Thomas A Rasmussen; Sharon R Lewin
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Residual immune dysregulation syndrome in treated HIV infection.

Authors:  Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 5.  Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.

Authors:  Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 6.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

7.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Authors:  Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  EBioMedicine       Date:  2015-06-27       Impact factor: 8.143

8.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

9.  Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function.

Authors:  K C Jambo; D H Banda; A M Kankwatira; N Sukumar; T J Allain; R S Heyderman; D G Russell; H C Mwandumba
Journal:  Mucosal Immunol       Date:  2014-01-29       Impact factor: 7.313

10.  A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?

Authors:  Michael M Lederman; Paula M Cannon; Judith S Currier; Carl H June; Hans Peter Kiem; Daniel R Kuritzkes; Sharon R Lewin; David M Margolis; Joseph M McCune; John W Mellors; Timothy W Schacker; Rafick P Sekaly; Pablo Tebas; Bruce D Walker; Daniel C Douek
Journal:  Pathog Immun       Date:  2016
View more
  34 in total

1.  Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.

Authors:  Francesco R Simonetti; Jennifer A White; Camille Tumiotto; Kristen D Ritter; Mian Cai; Rajesh T Gandhi; Steven G Deeks; Bonnie J Howell; Luis J Montaner; Joel N Blankson; Albine Martin; Gregory M Laird; Robert F Siliciano; John W Mellors; Janet D Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-20       Impact factor: 11.205

2.  HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.

Authors:  Zahra Kiani; Julie Bruneau; Daniel E Geraghty; Nicole F Bernard
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Single-Cell Multiparametric Analysis of Rare HIV-Infected Cells Identified by Duplexed RNAflow-FISH.

Authors:  Mathieu Dubé; Daniel E Kaufmann
Journal:  Methods Mol Biol       Date:  2022

4.  Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.

Authors:  Stephen W Wietgrefe; Lijie Duan; Jodi Anderson; Guillermo Marqués; Mark Sanders; Nathan W Cummins; Andrew D Badley; Curtis Dobrowolski; Jonathan Karn; Amélie Pagliuzza; Nicolas Chomont; Gérémy Sannier; Mathieu Dubé; Daniel E Kaufmann; Paul Zuck; Guoxin Wu; Bonnie J Howell; Cavan Reilly; Alon Herschhorn; Timothy W Schacker; Ashley T Haase
Journal:  J Virol       Date:  2022-07-20       Impact factor: 6.549

Review 5.  Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses.

Authors:  Julian J Freen-van Heeren
Journal:  BioTech (Basel)       Date:  2021-10-11

6.  Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.

Authors:  Jesper D Gunst; Marie H Pahus; Miriam Rosás-Umbert; I-Na Lu; Thomas Benfield; Henrik Nielsen; Isik S Johansen; Rajesh Mohey; Lars Østergaard; Vibeke Klastrup; Maryam Khan; Mariane H Schleimann; Rikke Olesen; Henrik Støvring; Paul W Denton; Natalie N Kinloch; Dennis C Copertino; Adam R Ward; Winiffer D Conce Alberto; Silke D Nielsen; Maria C Puertas; Victor Ramos; Jacqueline D Reeves; Christos J Petropoulos; Javier Martinez-Picado; Zabrina L Brumme; R Brad Jones; Julie Fox; Martin Tolstrup; Michel C Nussenzweig; Marina Caskey; Sarah Fidler; Ole S Søgaard
Journal:  Nat Med       Date:  2022-10-17       Impact factor: 87.241

Review 7.  Tools for Visualizing HIV in Cure Research.

Authors:  Julia Niessl; Amy E Baxter; Daniel E Kaufmann
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 8.  The Contributions of Clinical Pharmacology to HIV Cure Research.

Authors:  Courtney V Fletcher; Shetty Ravi Dyavar; Arpan Acharya; Siddappa N Byrareddy
Journal:  Clin Pharmacol Ther       Date:  2021-04-18       Impact factor: 6.903

Review 9.  Recommendations for measuring HIV reservoir size in cure-directed clinical trials.

Authors:  Mohamed Abdel-Mohsen; Douglas Richman; Robert F Siliciano; Michel C Nussenzweig; Bonnie J Howell; Javier Martinez-Picado; Nicolas Chomont; Katharine J Bar; Xu G Yu; Mathias Lichterfeld; Jose Alcami; Daria Hazuda; Frederic Bushman; Janet D Siliciano; Michael R Betts; Adam M Spivak; Vicente Planelles; Beatrice H Hahn; Davey M Smith; Ya-Chi Ho; Maria J Buzon; Christian Gaebler; Mirko Paiardini; Qingsheng Li; Jacob D Estes; Thomas J Hope; Jay Kostman; Karam Mounzer; Marina Caskey; Lawrence Fox; Ian Frank; James L Riley; Pablo Tebas; Luis J Montaner
Journal:  Nat Med       Date:  2020-09-07       Impact factor: 87.241

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.